Division of Medical Oncology
University of Colorado Denver
12801 E. 17th Avenue
Aurora, CO 80010
Ph: (303) 724-3888
Fax: (303 724-3889 info@deptofmed.edu
Colin D. Weekes, M.D., Ph.D.
Assistant Professor,
Education: University of Nebraska Medical Center, 2000
University of Colorado Denver
School of Medicine, Division of Medical Oncology
Tel: (303) 724-3808
Fax: (303) 724-3892
e-mail: colin.weekes@uchsc.edu
Bio
Dr. Weekes initially trained at the University of Nebraska Medical Center where he completed a combined M.D., Ph.D program. His graduate training was in cell biology and focused on lymphoma cell chemotherapy resistance. Following completion of medical school, he matriculated through a internal medicine residency at the University of Alabama Birmingham. Dr. Weekes focused on the translational research in the development of novel therapies for pancreatic cancer during my medical oncology fellowship at Johns Hopkins Hospital.
Research
Dr. Weekes is a junior faculty member of the Developmental Therapeutics and Gastro-Intestinal Malignancies Programs. Clinically, he has an active clinic focused on the management of all gastrointestinal malignancies and early phase clinical studies as part of the developmental therapeutics clinic. In addition, he directs a translational research laboratory focused on developing therapies targeting the tumor microenvironment for the treatment GI malignancies. Dr Weekes is an active member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR) as well as the Pancreatic Cancer Research Team.
Publications
Sharp J.G., Mann S.L., Murphy B.O., Weekes, C.D.: Culture Methods for the Detection of Minimal Tumor Contamination of Hematopoietic Harvests: A Review. J of Hematotherapy 4:141,1995.
Weekes CD, Pirrucello SJ, Vose JM, Kuszynski C and Sharp JG. Lymphoma Cells Associated with Bone Marrow Stromal Cells in Culture Exhibit Altered Growth and Survival. Leukemia and Lymphoma. 31:151, 1998.
Weekes CD, Kuszynski C and Sharp JG. VLA-4 Mediated Adhesion to Bone Marrow Stromal Cells confers Chemoresistance to Adherent Lymphoma Cells. Leukemia and Lymphoma. 40:631, 2001.
Weekes CD, Vose JM, Lynch JC, Weisenburger DD, et.al. Hodgkin’s Disease in the Elderly – Improved Treatment Outcome with A Doxorubicin-Containing Regimen. J.Clin. Oncol. 20:1087, 2002.